Quantcast

Medical Jane Develops New Tools to Promote Cannabis Education, Help End Prohibition

January 17, 2014

Medical Jane, LLC, a leading technology company in the cannabis industry, launches a redesigned website to help end prohibition through collaboration and education.

Los Angeles, CA (PRWEB) January 17, 2014

Medical Jane, LLC, a leading technology company in the cannabis industry, has officially launched their redesigned website geared towards educating the masses about the potential therapeutic benefits of cannabis.

As it stands, cannabis is classified as a Schedule 1 drug under the US Controlled Substances Act passed in 1970. Substances with this classification are said to be addictive, dangerous, and have no accepted medical value by definition.

Nonetheless, it seems that both science and public opinion disagree with the government in this regard. Clinical studies suggest that medical cannabis may have a number of health benefits. Further, a Gallup Poll released in October found that 58 percent of Americans now support cannabis legalization.

“It will take a community effort to combat the anti-cannabis propaganda that has run rampant for decades,” says Matthew Price, Medical Jane™ Founder & CEO. "Despite some lingering social stigmas, general interest in medical marijuana is growing rapidly. The foundations of cannabis prohibition are beginning to crumble."

According to Mr. Price, the company intends to unite the cannabis community through providing educational tools based on scientific research and professional expert opinions, in an attempt to challenge cannabis prohibition in the United States.

An FBI crime report released in September revealed that 749,824 arrests were made for cannabis-related offenses in 2012. Extrapolating that number, we find that one non-violent cannabis arrest occurred every 42 seconds in the United States. Mr. Price explains that this stems from both misinformation and a lingering social stigma that has plagued the cannabis community for decades.

In turn, he has designed Medical Jane’s new website to provide users with a plethora of educational tools. There you will find interactive genetic trees for each cannabis strain. Similarly the newly-released Cannabis Classroom™ provides medical marijuana patients with ailment-specific cannabinoid health articles. Each of these tools are intertwined into a new social community, allowing like-minded individuals to connect and share their experiences.

"This is just the beginning," Mr. Price insists. "We have plans to release more ground-breaking website features for the cannabis community each and every week."

Frequently referred to as the WebMD™ for the cannabis industry, Medical Jane is known for regularly providing professionally written, cannabis-related health and science information to its readers. Medical Jane's team plans to leverage its experience and background in technology to create something truly revolutionary for this developing industry. They believe their efforts will help curb cannabis prohibition and change global perceptions surrounding the cannabis plant.

Of course, the company's decision to emphasize an online community is nothing new. In just over a year, the Medical Jane Facebook page has quickly become one of the most active and controversial walls in the world. Sparking debate from people around the globe about the medicinal benefits of cannabis, Medical Jane has built a thriving network of over 250,000 social followers. Their new website is already home to roughly 420,000 organic visitors per month and growing fast.

About Medical Jane, LLC

Medical Jane is a multi-faceted resource that empowers medical marijuana patients and cannabis activists with industry news, information about strains, companies, events, and influential people in the industry. The site implements a number of tools, serving as a platform to bridge the gap between patients, cultivators, and everyone in between.

For more information, please visit http://www.medicaljane.com/.

For the original version on PRWeb visit: http://www.prweb.com/releases/medical/marijuana/prweb11495608.htm


Source: prweb



comments powered by Disqus